Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy

Clinical Neurophysiology

Volumn 111, Issue 12, 2000, Pages 2285-2291

  Stojkovic, T ^a,c   De Seze, J ^a   Hurtevent, J F ^a   Arndt, C ^a   Beaume, A ^b   Hache, J C ^a   Vermersch, P ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Central nervous system; Chronic demyelinating inflammatory polyneuropathy; Visual evoked potential; Visual evoked potentials

Indexed keywords

ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GANGLIOSIDE GM1; GLYCOLIPID; IMMUNOGLOBULIN; STEROID;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; EVOKED VISUAL RESPONSE; EYE; FEMALE; HUMAN; IDIOPATHIC DISEASE; INFLAMMATORY DISEASE; LATENT PERIOD; MALE; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BRAIN; CHRONIC DISEASE; DEMYELINATING DISEASES; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 0033757511     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(00)00478-8     Document Type: Article

References (30)

1. Evoked potentials to test a treatment of chronic multiple sclerosis
2. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system
3. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy
4. Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy
5. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy
6. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis
7. Central lesions in chronic inflammatory demyelinating polyneuropathy
8. Vasculitis of the central nervous system
9. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study
10. Human monoclonal IgM autoantibody activity against two glycolipids (GM1 and GD1b) in a patient with motor neuron syndrome
11. Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment
12. Steroid-responsive multifocal demyelinating neuropathy with central involvement
13. Chronic inflammatory demyelinating polyneuropathy
14. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy
15. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy
16. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect
17. Neurophysiological evaluation of associated demyelinating peripheral neuropathy and multiple sclerosis: a case report
18. Chronic multifocal demyelinating neuropathy associated with central nervous system demyelination
19. Evoked potentials predict the clinical changes in a multiple sclerosis drug study
20. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study
21. Evoked potentials in chronic inflammatory demyelinating polyneuropathy
22. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates
23. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
24. Combined central and peripheral myelinopathy
25. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
26. T cell-mediated maintenance of nature self-tolerance: its breakdown as a possible cause of various autoimmune diseases
27. Short-term neurophysiological monitoring in multiple sclerosis bouts. Evaluation of steroids treatment
28. Presentation and initial course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy
29. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination
30. CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study